4.7 Article

Prediction of anticancer peptides against MCF-7 breast cancer cells from the peptidomes of Achatina fulica mucus fractions

Journal

Publisher

ELSEVIER
DOI: 10.1016/j.csbj.2015.11.005

Keywords

Peptidomics; Cytotoxic peptides; Achatina fulica; Breast cancer; Bioinformatics prediction; Snail mucus

Funding

  1. Kasetsart University Research and Development Institute (KURDI) [KURDI-2.56]
  2. Faculty of Science, Kasetsart University [KURDI-02-2556]
  3. Development and Promotion of Science and Technology Talent Project (DPST) [DPST-SC-KU-013-2556]
  4. Do Day Dream Co., Ltd. [SNAILWHITE-01-2558]

Ask authors/readers for more resources

Several reports have shown antimicrobial and anticancer activities of mucous glycoproteins extracted from the giant African snail Achatina fulica. Anticancer properties of the snail mucous peptides remain incompletely revealed. The aim of this study was to predict anticancer peptides from A. fulica mucus. Two of HPLC-separated mucous fractions (F2 and F5) showed in vitro cytotoxicity against the breast cancer cell line (MCF-7) and normal epithelium cell line (Vero). According to the mass spectrometric analysis, 404 and 424 peptides from the F2 and F5 fractions were identified. Our comprehensive bioinformatics workflow predicted 16 putative cationic and amphipathic anticancer peptides with diverse structures from these two peptidome data. These peptides would be promising molecules for new anti-breast cancer drug development. (C) 2015 The Authors. Published by Elsevier B.V. on behalf of the Research Network of Computational and Structural Biotechnology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available